How Is AbbVie (NYSE:ABBV) Shaping Its S&P 500 Healthcare Profile?
Kalkine Media
AbbVie (NYSE:ABBV) is actively shaping its healthcare profile through various strategic initiatives. Its Allergan Aesthetics division recently released a global study on shifting consumer attitudes towards aesthetic care, highlighting a move towards ongoing treatment regimens. Concurrently, AbbVie submitted a European regulatory application for a subcutaneous induction option within its immunology franchise, aimed at providing more convenient treatment for Crohn's disease. These actions, alongsi
Read the full story
This is a short summary. The complete article is published by Kalkine Media.
Headline and summary aggregated from public news feeds. For information only — not financial advice.